Trial Profile
Roflumilast onset of action and effects of withdrawal in patients with COPD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Oct 2011
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Oct 2011 New trial record
- 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.